Tagged drug-delivery

AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
Press Release

AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities

 Read More
Orlance Announces Strategic Collaboration With Product Creation Studio for the Development of the MACH-1 System
Press Release

Orlance Announces Strategic Collaboration With Product Creation Studio for the Development of the MACH-1 System

 This Collaboration is Focused on Advancing the Design of the MACH-1 System, Preparing It for Phase 1 Clinical Trials Read More
Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs
Press Release

Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs

 Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site Read More
SingleTimeMicroneedles, CEO Jasdeep Singh, Wins 2024 SXSW Pitch Competition
Press Release

SingleTimeMicroneedles, CEO Jasdeep Singh, Wins 2024 SXSW Pitch Competition

 SingleTimeMicroneedles wins the Food, Nutrition, and Health Category. Read More
Health Advance Partners Closes SingleTimeMicroneedles’ Pre-Seed Funding Round
Press Release

Health Advance Partners Closes SingleTimeMicroneedles’ Pre-Seed Funding Round

 Health Advance Partners Agree to Equity Stake in SingleTimeMicroneedles at a $3.5 Million Valuation Read More
Press Release

Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers

 Read More
SingleTimeMicroneedles, Inc. Selected as Finalist for 2024 SXSW Pitch
Press Release

SingleTimeMicroneedles, Inc. Selected as Finalist for 2024 SXSW Pitch

 SingleTimeMicroneedles to showcase STM Patch in the Food, Nutrition, and Health category Read More
Press Release

New Nanocarrier Technology Promises Breakthrough in Delivery of Therapeutic Drugs Through Mucosal Membranes

 Research is currently underway to develop Cystic Fibrosis treatments Read More
ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network
Press Release

ApiLabs, R&D Sister Company to ApiJect, Launches Its Field Research Network

 Read More
LayerBio Granted U.S. Patent for OcuRing™ Drug Delivery Platform
Press Release

LayerBio Granted U.S. Patent for OcuRing™ Drug Delivery Platform

 Novel sustained-release technology has potential to eliminate the need for eye drops after cataract surgery. Read More
LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery
Press Release

LayerBio Awarded $3M From U.S. Department of Defense (DoD) to Advance OcuRing™ for Cataract Surgery

 OcuRing™ is a novel drug delivery platform for cataract surgery with potential to eliminate the need for postoperative topical eye drops. $3M DoD award will fund IND-enabling toxicology and manufacturing activities. LayerBio plans to develop OcuRing™ products for multiple cataract surgery-related indications. Read More
Rapid Self-Healing Gel Market Valuation to Surpass $310 Million by 2025, Says Global Market Insights, Inc.
Press Release

Rapid Self-Healing Gel Market Valuation to Surpass $310 Million by 2025, Says Global Market Insights, Inc.

 The overall growth of the rapid self-healing gel market is fueled by consistent advancements in the field of wound healing, which is also shaping up to be a primary factor that is likely to significantly influence market growth in a positive manner by 2025. Read More
Press Release

Phoenix Solutions Enters Clinical Phase

 Read More
Press Release

Phoenix Solutions AS Strengthens Its Board With the Appointment of Dr. Jean-Michel Cosséry

 Read More
Medical Biomimetics Market Value to Hit $35 Billion by 2025: Global Market Insights, Inc.
Press Release

Medical Biomimetics Market Value to Hit $35 Billion by 2025: Global Market Insights, Inc.

 U.S. medical biomimetics market dominated North America region with more than 90% revenue share in 2018 and is anticipated to achieve significant CAGR from 2019 to 2025 owing to growing burden of chronic diseases. Read More
Press Release

EastGate Biotech Appoints World-Renowned Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

 Key Opinion Leader spreading awareness of diabetes endorses the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients Read More
Expediting Dry Powder Inhaler Formulation Development Through Modelling and Advanced Characterization, New Webinar Hosted by Xtalks
Press Release

Expediting Dry Powder Inhaler Formulation Development Through Modelling and Advanced Characterization, New Webinar Hosted by Xtalks

 Dry powder inhalers are gaining increasing momentum for drug delivery to the lungs. One of the most used and flexible delivery technologies are capsule-based dry powder inhalers Read More
Press Release

EastGate Biotech Receives Approval to Commence a Phase 2 Trial for Liquid Insulin Mouth Rinse Solution Addressing Patient Compliance in the Type 2 Diabetes Market

 DRAP (Drug Regulatory Authority Pakistan) provided approval to commence studies of INSUGIN in Pakistan Read More
Press Release

Sir William Castell Joins the Board of Phoenix Solutions AS, a Private Norwegian Biotechnology Company Harnessing the Power of Ultrasound for Targeted Drug Delivery

 Read More
Press Release

EastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution

 Non-Dilutive Investment and Product License includes licensing fee and development costs Read More
Press Release

EastGate Biotech Provides Update on Investment From Genluiching Mining Corporation

 EastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement. Read More
NanoCarrier Announces the Opening of a US Subsidiary as Part of Its Global Expansion Plans and the Hiring of a Managing Director
Press Release

NanoCarrier Announces the Opening of a US Subsidiary as Part of Its Global Expansion Plans and the Hiring of a Managing Director

 Read More
ivWatch Wins Top Honors at 2017 Medical Design Excellence Awards
Press Release

ivWatch Wins Top Honors at 2017 Medical Design Excellence Awards

 Read More
ivWatch Closes $14.8 Million Funding Round
Press Release

ivWatch Closes $14.8 Million Funding Round

 Read More
ivWatch Launches OEM Solution, Expands Executive Team to Support Global Sales and Partnerships
Press Release

ivWatch Launches OEM Solution, Expands Executive Team to Support Global Sales and Partnerships

 Read More
Pulmatrix's CEO Eyes $25 Billion COPD Market for Its Inhaled Drug Delivery Technology
Press Release

Pulmatrix's CEO Eyes $25 Billion COPD Market for Its Inhaled Drug Delivery Technology

 In an Interview With Stock-Sector, Dr. Clarke Explains How Pulmatrix Is Targeting Major Markets With the iSPERSE Technology Platform That Delivers Drugs to the Lungs More Efficiently Read More
Press Release

Aciont® to Present at ARVO 2011 Annual Meeting

 Aciont's poster "Importance of the Conjunctiva in Transscleral Iontophoresis" will be shown on May 3, 2011 at the meeting. Read More
Press Release

Aciont® Strengthens Management Team with Industry Leader in Ophthalmic Product Development

 Balbir Brar brings 25 years of drug and device development experience to Aciont Inc. Read More
Press Release

NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont®

 The National Eye Institute (NEI), a division of the National Institutes of Health (NIH), awarded a $2.18 million grant to Aciont Inc. to help fund its development of a non-invasive, passive diffusion-based treatment for severe, non-infectious uveitis Read More